Axsome Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AXSM and other ETFs, options, and stocks.

About AXSM

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview.

CEO

Herriott Tabuteau

CEOHerriott Tabuteau

Employees

925

Employees925

Headquarters

New York, New York

HeadquartersNew York, New York

Founded

2012

Founded2012

Employees

925

Employees925

AXSM Key Statistics

Market cap

12.64B

Market cap12.64B

Price-Earnings ratio

-65.69

Price-Earnings ratio-65.69

Dividend yield

—

Dividend yield—

Average volume

712.53K

Average volume712.53K

High today

$246.41

High today$246.41

Low today

$236.38

Low today$236.38

Open price

$237.21

Open price$237.21

Volume

875.01K

Volume875.01K

52 Week high

$246.41

52 Week high$246.41

52 Week low

$96.09

52 Week low$96.09

Stock Snapshot

With a market cap of 12.64B, Axsome Therapeutics(AXSM) trades at $245.64. The stock has a price-to-earnings ratio of -65.69.

On 2026-06-09, Axsome Therapeutics(AXSM) stock moved within a range of $236.38 to $246.41. With shares now at $245.64, the stock is trading +3.9% above its intraday low and -0.3% below the session's peak.

Trading volume for Axsome Therapeutics(AXSM) stock has reached 875.01K, versus its average volume of 712.53K.

Over the past 52 weeks, Axsome Therapeutics(AXSM) stock has traded between a high of $246.41 and a low of $96.09.

AXSM News

TipRanks 4h

Axsome Shareholders Back Directors, Auditor and Executive Pay

Axsome Therapeutics ( (AXSM) ) has provided an update. At Axsome Therapeutics’ 2026 Annual Meeting of Stockholders held on June 5, 2026, shareholders voted on...

TipRanks 4h

Axsome adopts new executive severance and control plan

Axsome Therapeutics ( (AXSM) ) has shared an announcement. On June 5, 2026, Axsome Therapeutics’ board-level Compensation Committee approved an Executive Sever...

Investing.com 12h

Axsome Therapeutics stock hits all-time high at 242.5 USD - Investing.com

...

Analyst ratings

90%

of 21 ratings

Buy

90.5%

Hold

9.5%

Sell

More AXSM News

TipRanks 7d

Axsome Therapeutics announces settlement resolving Sunosi patent litigation

Axsome Therapeutics (AXSM) announced that it has resolved all patent litigation related to Axsome’s product Sunosi. The litigations resulted from submission of...

People also own

Based on the portfolios of people who own AXSM. This list is generated using Robinhood data, and it’s not a recommendation.

Taiwan Semiconductor Manu…

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.